Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 5,550.00
+30.00 (0.54%)
At close: Sep 11, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 71.85 billion as of September 11, 2026. Its market cap has decreased by -7.81% in one year.
Market Cap
71.85B
Enterprise Value
58.41B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,550.00
ChartMarket Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 71.85B, a decrease of -36.29%. That is a compound annual growth rate of -13.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 71.85B | -40.89% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 84.88B |
| Sam-A Pharm. | 84.84B |
| KOREA PHARMA | 83.65B |
| Samik Pharmaceutical Company LTD. | 83.56B |
| Daehan Nupharm | 78.74B |
| Polaris AI Pharma | 72.79B |
| GL Pharm Tech | 72.66B |
| Sinsin Pharmaceutical | 70.47B |